Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Expert Opinion on Drug Safety|September 11, 2018
Drugs that increase the risk of community-acquired pneumonia: a narrative reviewAdamantia Liapikou, Catia Cilloniz, Antoni TorresInfectious Disease Clinics of North America|February 13, 2013
What is the best approach to the nonresponding patient with community-acquired pneumonia?Salvador Sialer, Adamantia Liapikou, Antoni TorresExpert Review of Respiratory Medicine|May 20, 2014
The management of severe community acquired pneumonia in the intensive care unitAdamantia Liapikou, Edmundo Rosales-Mayor, Antoni TorresExpert Opinion on Pharmacotherapy|March 4, 2014
Pharmacotherapy for hospital-acquired pneumoniaAdamantia Liapikou, Edmundo Rosales-Mayor, Antonio TorresExpert Opinion on Pharmacotherapy|September 14, 2014
Pharmacotherapy for lower respiratory tract infectionsAdamantia Liapikou, Liapikou Adamantia, Antoni Torres, et al.Expert Opinion on Emerging Drugs|October 29, 2019
Emerging antibiotics for community-acquired pneumoniaAdamantia Liapikou, Catia Cilloniz, Andrea Palomeque, et al.Pulmonary Pharmacology & Therapeutics|June 1, 2014
New antimicrobial approaches to gram positive respiratory infectionsAdamantia Liapikou, Catia Cilloniz, Josep Mensa, et al.Journal of Personalized Medicine|December 24, 2025
Birt-Hogg-Dubé Syndrome: A Mini Review of the Clinical Manifestations, Investigation, and ManagementChristina Ntinidi, Ioannis Tomos, Andreas M Matthaiou, et al.Rural and Remote Health|June 16, 2020
Community acquired pneumonia: a cost-of-illness analysis in GreecePanagiota Naoum, Kostas Athanasakis, Ilias Kyriopoulos, et al.Journal of Personalized Medicine|August 27, 2021
Outpatient Management of COVID-19 Disease: A Holistic Patient-Centered Proposal Based on the Greek ExperienceAdamantia Liapikou, Eleni Tzortzaki, Georgios Hillas, et al.Pageof 4